Targeting prosurvival BCL2 signaling through Akt blockade sensitizes castration‐resistant prostate cancer cells to enzalutamide
Amanda Pilling(Henry Ford Health System), Clara Hwang(Henry Ford Health System)
Cited by 51
Related Papers
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
|JAMA Oncology|2021|185
The CoVID‐TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID‐19
|Journal of Thrombosis and Haemostasis|2021|30